News | February 22, 2010

Merge Healthcare Makes New Offer to Purchase AMICAS

February 22, 2010 – RIS/PACS maker Merge Healthcare Inc. said today it is making a bid to purchased the PACS company AMICAS. However, Amicas says it already entered into a merger deal with another company.

It its sixth proposal to purchased AMICAS, Merge said it has a pending $6.05 cash per share offer for AMICAS, totaling about $248 million. This represents a 13 percent premium to the previously announced offer for AMICAS from a newly formed affiliate of Thoma Bravo LLC for $5.35 cash per share.

In amended proxy materials filed today with the Securities and Exchange Commission, Amicas disclosed it received an unsolicited proposal from Merge Healthcare. Merge's highly-conditional proposal is dependent on third-party financing, subject to a "reverse break" fee, which essentially gives Merge a $10 million option to buy AMICAS; subject to a number of additional conditions, the satisfaction of which are within Merge's control, and has been characterized as Merge's "best and final" proposal. Given the highly conditional nature of Merge's most recent proposal, the AMICAS Board of Directors believes that the Merge proposal is illusory and risky to AMICAS stockholders. AMICAS said the Merge deal would also require it to terminate the Thoma Bravo merger and pay the break-up fee of $8.6 million, which AMICAS doubts it would recover from any deal with Merge.

As previously announced on Dec. 24, AMICAS entered into a definitive merger agreement with Thoma Bravo LLC, under which an affiliate of Thoma Bravo would acquire all of the outstanding shares of AMICAS for $5.35 per share in cash. This purchase price is fully financed and guaranteed by Thoma Bravo and other first tier private equity funds and is not dependent on unguaranteed, third-party financing. AMICAS said Thoma Bravo was ready, willing and able to close the transaction on its originally scheduled closing date of Feb. 19, 2010. AMICAS said the Thoma Bravo merger provides AMICAS stockholders with immediate and certain cash value. AMICAS is confident that the Thoma Bravo Merger can be completed in a timely manner immediately following stockholder approval at the special meeting of stockholders scheduled March 4.

AMICAS said it has been advised Thoma Bravo remains fully committed to the transaction.

The AMICAS board and management team actively engaged with Merge and its advisors in an attempt to negotiate a transaction that is in the best interest of AMICAS' stockholders. But after carefully reviewing Merge's most recent proposal, the AMICAS board, consulting with its independent financial and legal advisors, determined the proposal is not a in the best interests of the company. The company said Merge failed to provide sufficient financial guarantees and reasonable protections for AMICAS stockholders.

Merge’s current offer follows its offer of $6 cash per share. The offer was made during the 45-day "go-shop" period in the deal with Thoma Bravo. The period ended Feb. 7, but allowed AMICAS to solicit and negotiate alternative proposals.

Merge intervened in Massachusetts litigation challenging the adequacy of AMICAS’ disclosures relating to this transaction, as well as the process by which its proposals have been considered by the AMICAS Board of Directors.

Merge said it received a signed bridge financing commitment from Morgan Stanley to provide $200 million of debt financing. Based on that commitment and available cash, including $40 million of prefunded equity investments from mezzanine investors, Merge has proposed to commence a $6.05 cash per share tender offer for all AMICAS shares and to close the acquisition as quickly as possible thereafter.

Merge develops solutions that automate healthcare data and diagnostic workflow to enable a better electronic record of the patient experience, and to enhance product development for health IT, device and pharmaceutical companies. Healthcare providers, vendors and researchers use merge products, ranging from standards-based development toolkits to sophisticated clinical applications.

AMICAS is a leading independent provider of imaging IT solutions. It offers image and information management solutions, including radiology PACS, cardiology PACS, radiology information systems, cardiovascular information systems, revenue cycle management solutions and enterprise content management tools designed to power the imaging component of the electronic medical record (EMR).

For more information: www.merge.com, www.amicas.com

Related Content

News | Enterprise Imaging | November 14, 2018
Konica Minolta Healthcare Americas Inc. will showcase new features and tools for the Exa Enterprise Imaging platform at...
Deaconess Health System Chooses Sectra as Enterprise Imaging Vendor
News | Enterprise Imaging | November 02, 2018
International medical imaging information technology (IT) and cybersecurity company Sectra will install its enterprise...
Carestream Spotlights Healthcare IT and Imaging Systems at RSNA 2018
News | Information Technology | October 31, 2018
Carestream announced it will be displaying several imaging and healthcare information technology (IT) offerings at the...
Cullman Regional Medical Center

Cullman Regional Medical Center (Alabama) is a 145-bed medical center serving more than 175,000 residents in a six-county area and recognized as one of the region’s finest medical facilities.

Sponsored Content | Case Study | PACS | October 05, 2018
When Cullman Regional Medical Center in Alabama decided to switch from 2-D
Agfa Introducing New MUSICA Workstation at RSNA 2018
News | PACS Accessories | October 04, 2018
At the 2018 Radiological Society of North America (RSNA) annual meeting, Nov. 26-30 in Chicago, Agfa HealthCare will...
Intelerad Medical Systems Appoints New President and CEO
News | Enterprise Imaging | September 25, 2018
September 25, 2018 — Intelerad Medical Systems announced that following the retirement of Randall Oka, its board of d
Laurel Bridge Enables Healthcare Providers to Manage Image Archive Migrations and Consolidations
News | Enterprise Imaging | September 25, 2018
September 25, 2018 — Laurel Bridge Software announced improvements to their Exodus Migration and Consolidation Contro
Sponsored Content | Case Study | Information Technology | September 07, 2018
One of the Northeast’s major teaching hospitals is an international leader in virtually every area of medicine. It has...
Mount Sinai Serves as Official Medical Services Provider for 2018 U.S. Open
News | Orthopedic Imaging | September 06, 2018
For the sixth consecutive year, Mount Sinai will serve as the official medical services provider for the 2018 U.S. Open...